TESAMORELIN 10mg

Sale!
TESAMORELIN 10mg
A$130.00 A$110.00

Documentation: Batch-specific Certificates of Analysis (COAs) are included within the product image gallery for reference.

 


FOR RESEARCH USE ONLY 

Intended Use: This product is supplied strictly for laboratory research use only. Not for human or veterinary use.

 


Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH) designed to stimulate endogenous growth hormone secretion via receptor-mediated mechanisms. It has been investigated in clinical and research settings for its effects on growth hormone dynamics and associated metabolic pathways.

 

In Australia, tesamorelin is not included on the Australian Register of Therapeutic Goods (ARTG) and is not approved by the Therapeutic Goods Administration (TGA) for the prevention, diagnosis, treatment, or cure of any disease or medical condition.


Technical Specifications – Tesamorelin


10 mg Total Peptide Content

 

Product Composition

  • Tesamorelin (TH9507): 10 mg
    (Synthetic Growth Hormone–Releasing Hormone [GHRH] analog with trans-3-hexenoic acid modification)

Total Contents: 10 mg lyophilized peptide powder

Tesamorelin – Specification (10 mg)

  • Name: Tesamorelin (TH9507)
  • Type: Synthetic GHRH (1–44) analog
  • Sequence (44-amino-acid peptide):
    Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Glu-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Gln-Lys-Gly-Gly-Gly-E (hexenoyl modification)
  • Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
  • Molecular Weight: ~5,066.57 Da
  • CAS Number: 218949-48-5
  • Purity: ≥ 98–99% (HPLC-verified)
  • Physical Form: Lyophilized white/off-white peptide powder

Solubility

  • Soluble in sterile water or mild aqueous buffers
  • Avoid highly acidic or alkaline conditions
  • Mix gently—do not shake aggressively

Storage

  • Before reconstitution:
    –20 °C or below, protected from heat, light, and moisture
  • After reconstitution:
    2–8 °C; do not freeze
  • Use within standard laboratory stability windows
  • Avoid repeated freeze–thaw cycles

General Handling Notes

  • Reconstitute using aseptic technique
  • Use sterile or bacteriostatic diluent only
  • For in-vitro or ex-vivo laboratory research applications
  • Not for clinical or therapeutic use

 


Product Disclaimer

 

This product is supplied strictly for laboratory research use only. It has not been evaluated or approved by any regulatory authority—including but not limited to the FDA, EMA, MHRA, or Australian TGA—for human therapeutic, diagnostic, clinical, or veterinary use. The purchaser assumes full responsibility for proper handling, storage, and disposal in accordance with institutional, local, and national regulations.

 

No claims are made regarding the safety, efficacy, or suitability of this material for medical, therapeutic, or cosmetic purposes. This product must not be ingested, injected, inhaled, implanted, applied topically, or administered to humans or animals outside of an approved research protocol conducted under appropriate regulatory oversight and using GMP-grade material.

 

This product is intended exclusively for qualified laboratory personnel trained in peptide handling, analytical methods, and biosafety procedures. Keep out of reach of children and untrained individuals. It is supplied “as is,” with no warranty—express or implied—regarding merchantability, fitness for a particular purpose, or non-infringement. Users should review all relevant safety data, hazard statements, and institutional biosafety requirements prior to handling.